Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth 
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO 
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand 
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports 
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit 
Luxury Car Sales in the Middle East Take a Hit Amid Iran War 
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition 
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers 
TSMC Japan's Second Fab to Produce 3nm Chips by 2028 
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook 
Cybersecurity Stocks Tumble After Anthropic's Claude Mythos AI Leak Sparks Market Fears 
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation 
Bank of America's $72.5M Epstein Settlement: What You Need to Know 
Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal 
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal 
Nomura Upgrades PDD Holdings to Buy, Calls Stock Too Cheap to Ignore 
Federal Judge Blocks Pentagon's Blacklisting of AI Company Anthropic 
BURLINGTON, Mass., Sept. 05, 2017 -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be participating in three investor conferences.
JJ Pellegrino, Chief Financial Officer, is scheduled to present at the R.W. Baird 2017 Healthcare Conference on Thursday, September 7, 2017 at the InterContinental New York Barclay Hotel in New York City. The Company’s presentation is scheduled to begin at 1:25 PM EDT.
JJ Pellegrino, Chief Financial Officer, will participate in the Morgan Stanley 15th Annual Global Healthcare Conference on Monday, September 11, 2017 at the Grand Hyatt in New York City.
David Roberts, President, is scheduled to present at the Cantor Fitzgerald Global Healthcare Conference on Tuesday, September 26, 2017 at the InterContinental New York Barclay Hotel in New York City. The Company’s presentation is scheduled to begin at 2:15 PM EDT.
About LeMaitre Vascular
LeMaitre Vascular is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. Additional information can be found at www.lemaitre.com.
Contact: LeMaitre Vascular, Inc. Investor Relations Steven Chehames +1-781-425-1659 [email protected]
